Skip to main content
. Author manuscript; available in PMC: 2020 Dec 26.
Published in final edited form as: Equine Vet J. 2016 Jan 16;49(1):79–86. doi: 10.1111/evj.12547

TABLE 1:

Viral vector injection scenario into the equine distal extremity

Horse Foot Serotype Promoter Transgene Dose Diluent Duration (days)
A L rAAV 2/8 CB nLacZ 1.0 × 1013 Saline 7
R rAAV 2/5 CB nLacZ 1.0 × 1013 Saline
B L rAAV 2/8* CMV eGFP 1.0 × 1013 Saline 7
R rAAV 2/5 CMV eGFP 1.0 × 1013 Saline
C L rAAV 2/8 CB nLacZ 6.0 × 1013 Saline 7
R rAAV 2/1 CB nLacZ 6.0 × 1013 Saline
D L rAAV 2/8* CMV eGFP 3.0 × 1013 Saline 21
R rAAV 2/8* CMV eGFP 3.0 × 1013 Surfactant
E L rAAV 2/8 CB nLacZ 2.0 × 1013 Saline 7
R rAAV 2/8 CB nLacZ 6.0 × 1012 Saline
F L rAAV 2/9 CB nLacZ 1.0 × 1013 Saline 7
R rAAV 2/9 CB nLacZ 1.0 × 1013 Surfactant
G L rAAV 2/9 CB nLacZ 1.0 × 1013 Saline 14
R rAAV 2/9 CB nLacZ 1.0 × 1013 Surfactant

L, left; R, right.

*

This vector had been previously thawed and refrozen, which may have compromised its potency. Dose = viral copies (VC) injected.